EKB Journal Management System


1.	Biosimilars Revolution
	Pages 1-2
	M. Salah Abdel Baky
	View Article PDF 68.38 K

2.	When to Start Urate Lowering Therapy?
	Pages 3-5
	Adel AE
	View Article PDF 94.2 K

3.	Psychosocial Aspects of Rheumatic Diseases
	Pages 7-8
	AbdelAzeim Elhefny
	View Article PDF 72.47 K

4.	Urinary Podocalyxin and Lupus Nephritis Disease Activity
	Pages 15-22
	Ashraf Mohamed; Mahmoud Awad; Asmaa Enein; Mona Balata; Alaa Alsalawy; Emad Elmasry
	View Article PDF 859.96 K

5.	Assessment of Neutrophil Lymphocyte Ratio in Systemic Sclerosis Patients in Tanta University Hospital: A Promising Marker in Predicting Disease Severity
	Pages 33-41
	Noha Esheba; Abeer Shahba
	View Article PDF 118.19 K

6.	Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity
	Pages 43-47
	Eman Rashwan; Mai Moaaz; Nevine Mohannad; Mohamed Rahman; Eman Zaghloul
	View Article PDF 193.75 K

7.	Study of Peptidyl Arginine Deiminases 4 (PAD 4) Antibodies in Rheumatoid Arthritis Patients
	Pages 49-58
	Darwish El-Hallous; Nevine Mohannad; Maher Kamel; El-Sayed Radwan
	View Article PDF 209.03 K

8.	Assessment of Cytotoxicity and Genotoxicity in Patients with Rheumatoid Arthritis and its Relation to Disease Activity and Medications
	Pages 59-66
	Sally Tayel; Manal Tayel; Hanan Mahrous; Eiman Soliman
	View Article PDF 449.54 K

9.	Evaluation of Adherence to Drug Treatment in Patients with Rheumatoid Arthritis
	Pages 68-80
	Abd El-Azeim Alhefny; Maryam Abd El-Rahman; Sameh Abd El-Moteleb; Hossam Sakr; Rasha Hassan
	View Article PDF 464.33 K

10.	Year in Review 2015-2016 Rheumatoid Arthritis 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis (December 2015)
	Pages 81-92

	View Article PDF 406.37 K

11.	Lupus mimickers…!
	Pages 93-94
	Howaida Mansour; Nahla Hussin; Rahma Elziaty; Warda Abdelfattah
	View Article PDF 733.56 K